Clinical Trial Update: The ORIGIN Trial (Outcome Reduction With Initial Glargine Intervention) [Phase 3]

View source ↗

Summary

Phase 3 trial ORIGIN evaluated initial insulin glargine intervention in adults with type 2 diabetes mellitus; the study is completed and results were posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Lantus (insulin glargine)

Snippet

Sponsor: Sanofi | Conditions: Diabetes Mellitus, Non-Insulin-Dependent | Phase 3 | Status: COMPLETED | Results posted: 2013-01-25